Use of ticagrelor in human pregnancy, the first experience

BMJ Case Rep. 2015 Nov 25:2015:bcr2015212217. doi: 10.1136/bcr-2015-212217.

Abstract

Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation. The patient, with Behçet disease, suffered from a non-ST elevation myocardial infarction 4 months before conception, possibly related to hypertension and tobacco abuse. Pregnancy and postpartum periods were uneventful. She delivered a healthy but small-for-gestational-age term neonate.

Publication types

  • Case Reports

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / therapeutic use
  • Adult
  • Aspirin / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Myocardial Infarction / complications
  • Myocardial Infarction / therapy
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pregnancy
  • Pregnancy Complications / prevention & control*
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Secondary Prevention*
  • Thromboembolism / prevention & control*
  • Ticagrelor

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Ticagrelor
  • Adenosine
  • Aspirin